Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
PUT
CoStar Group
CSGP
$12.1B
| $359K | ﹤0.01% |
13,100
-22,600
| -63% | -$679K |
2026 Q1
2 quarters
|
|
3602
Sierra Bancorp
BSRR
$545M
| $359K | ﹤0.01% |
+9,189
| New | +$373K |
2026 Q3
0 quarters
|
|
3603
HomeTrust Bancshares
HTB
$747M
| $359K | ﹤0.01% |
7,836
-191
| -2% | -$9.23K |
2026 Q2
1 quarter
|
|
3604
Fennec Pharmaceuticals
FENC
$382M
| $359K | ﹤0.01% |
33,672
+2,540
| +8% | +$27.9K |
2025 Q4
3 quarters
|
|
3605
Ridgepost Capital
RPC
$1.04B
| $358K | ﹤0.01% |
48,191
+36,271
| +304% | +$302K |
2026 Q1
2 quarters
|
|
3606
iShares MSCI Netherlands ETF
EWN
$604M
| $358K | ﹤0.01% |
+5,282
| New | +$360K |
2026 Q3
0 quarters
|
|
3607
Integra LifeSciences
IART
$1.12B
| $358K | ﹤0.01% |
+21,979
| New | +$379K |
2026 Q3
0 quarters
|
|
3608
Mission Produce
AVO
$1.01B
| $358K | ﹤0.01% |
27,286
-213,267
| -89% | -$2.76M |
2026 Q2
1 quarter
|
|
3609
CareTrust REIT
CTRE
$9.8B
| $358K | ﹤0.01% |
9,777
-4,948
| -34% | -$198K |
2026 Q1
2 quarters
|
|
3610
Citizens
CIA
$186M
| $357K | ﹤0.01% |
103,582
+37,126
| +56% | +$161K |
2026 Q1
2 quarters
|
|
3611
Coty
COTY
$3.55B
| $357K | ﹤0.01% |
136,659
-317,881
| -70% | -$843K |
2025 Q2
5 quarters
|
|
3612
CALL
Vail Resorts
MTN
$5.4B
| $357K | ﹤0.01% |
2,600
-11,600
| -82% | -$1.67M |
2024 Q2
9 quarters
|
|
3613
CALL
American Electric Power
AEP
$70.2B
| $356K | ﹤0.01% |
3,000
| – | – |
2022 Q1
18 quarters
|
|
3614
PUT
Dover
DOV
$27.9B
| $355K | ﹤0.01% |
+1,900
| New | +$383K |
2026 Q3
0 quarters
|
|
3615
CALL
Pan American Silver
PAAS
$15.6B
| $355K | ﹤0.01% |
7,800
+2,500
| +47% | +$119K |
2025 Q3
4 quarters
|
|
3616
MPLX
MPLX
$57.3B
| $355K | ﹤0.01% |
6,300
| – | – |
2026 Q1
2 quarters
|
|
3617
PUT
Neurocrine Biosciences
NBIX
$17.1B
| $355K | ﹤0.01% |
+2,500
| New | +$402K |
2026 Q3
0 quarters
|
|
3618
PUT
ResMed
RMD
$33.6B
| $354K | ﹤0.01% |
+1,600
| New | +$349K |
2026 Q3
0 quarters
|
|
3619
Repay Holdings
RPAY
$340M
| $353K | ﹤0.01% |
+97,530
| New | +$376K |
2026 Q3
0 quarters
|
|
3620
CALL
Suncor Energy
SU
$79.8B
| $353K | ﹤0.01% |
+5,200
| New | +$338K |
2026 Q3
0 quarters
|
|
3621
Universal Corp
UVV
$941M
| $352K | ﹤0.01% |
8,427
-14,774
| -64% | -$709K |
2024 Q4
7 quarters
|
|
3622
iShares 3-7 Year Treasury Bond ETF
IEI
$16.8B
| $351K | ﹤0.01% |
+3,097
| New | +$359K |
2026 Q3
0 quarters
|
|
3623
Kelly Services Class A
KELYA
$481M
| $350K | ﹤0.01% |
+21,609
| New | +$339K |
2026 Q3
0 quarters
|
|
3624
Huron Consulting
HURN
$2.64B
| $350K | ﹤0.01% |
2,231
-35,844
| -94% | -$5.09M |
2026 Q1
2 quarters
|
|
3625
PUT
Cheniere Energy
LNG
$63.2B
| $350K | ﹤0.01% |
1,300
-6,000
| -82% | -$1.61M |
2026 Q2
1 quarter
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.